GlassScriptPhysician profile
Andrew Joel
NPI 1992704340
$3,114.81
in general payments reported to CMS, 2019-2025
29 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $683 · 2020: $372 · 2021: $207 · 2022: $301 · 2023: $271 · 2024: $1,107 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,548 · Education: $3.02.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,548.39 |
| Education | $3.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $847.01 | 2019-2020 | |
| Edap Technomed INC | $714.00 | 2024 | |
| Abbvie INC. | $204.02 | 2022-2025 | |
| Procept Biorobotics Corporation | $149.83 | 2021 | |
| Sumitomo Pharma America, INC. | $149.74 | 2023-2024 | Orgovyx, Gemtesa |
| Olympus America INC. | $135.86 | 2021-2022 | |
| Astellas Pharma US INC | $123.73 | 2019-2024 | Myrbetriq, Veozah |
| Boston Scientific Corporation | $96.36 | 2024-2025 | Ams 700, Rezum Generator, Upsylon |
| Myriad Genetic Laboratories, INC. | $80.37 | 2024-2025 | Prolaris |
| Urovant Sciences INC | $63.78 | 2021-2022 | |
| Blue Earth Diagnostics | $60.92 | 2022 | |
| Photocure INC | $56.08 | 2019-2025 | Cysview |
| Tolmar, INC. | $52.67 | 2023-2024 | |
| Janssen Biotech, INC. | $42.03 | 2019-2023 | Erleada, Akeega |
| Renovia INC | $38.54 | 2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $35.44 | 2023 | |
| Laborie Medical Technologies Corp. | $30.53 | 2022 | |
| Ethicon US, LLC | $28.68 | 2023 | Echelon Flex, Stratafix |
| Cardinal Health 414 LLC | $28.60 | 2024 | |
| Ferring Pharmaceuticals INC. | $25.14 | 2024 | Adstiladrin |
| Janssen Pharmaceuticals, INC | $23.20 | 2019 | |
| Civco Medical Instruments | $22.47 | 2025 | |
| Becton, Dickinson and Company | $19.38 | 2019 | |
| Coloplast Corp | $19.20 | 2023 | Porges Coloplast |
| Urogen Pharma, INC. | $18.95 | 2025 | |
| Sagent Pharmaceuticals | $16.82 | 2019 | |
| Therapeuticsmd, INC. | $14.37 | 2021 | |
| Profound Medical Corp. | $14.07 | 2025 | Tulsa-Pro |
| Travere Therapeutics, INC. | $3.02 | 2025 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Joel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.